01409nam 2200373Ia 450 991069884780332120090518133513.0(CKB)5470000002397388(OCoLC)325057001(EXLCZ)99547000000239738820090518d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] compliance with 21 CFR part 1271.150(c)(1), manufacturing arrangementsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2006]i, 3 pages digital, PDF fileTitle from PDF title page (viewed on May 18, 2009)."September 2006".Includes bibliographical references (page 3).Guidance for industry Human cell cultureGovernment policyUnited StatesTissue engineeringGovernment policyUnited StatesHuman cell cultureGovernment policyTissue engineeringGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698847803321Guidance for industry3434577UNINA